Quantification of soy isoflavones and their conjugative metabolites in plasma and urine: an automated and validated UHPLC-MS/MS method for use in large-scale studies

被引:41
作者
Soukup, Sebastian T. [1 ]
Al-Maharik, Nawaf [2 ]
Botting, Nigel [2 ]
Kulling, Sabine E. [1 ]
机构
[1] Max Rubner Inst, Dept Safety & Qual Fruits & Vegetables, D-76131 Karlsruhe, Germany
[2] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland
关键词
Soy isoflavones; Sulfates; Sulfoglucuronides; Glucuronides; Clinical study; Automated sample preparation; HIGH-THROUGHPUT QUANTIFICATION; MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; LC-MS/MS; DAIDZEIN; PHYTOESTROGENS; IONIZATION; CELLS; GLUCURONIDES; DISPOSITION;
D O I
10.1007/s00216-014-8034-y
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The biotransformation of isoflavones by gut microbiota and by drug metabolizing enzymes plays a crucial role in the understanding of their potential health-promoting effects. The purpose of our work was to develop a simultaneous, sensitive, and robust automated ultra high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) method to quantify the soy isoflavones daidzein and genistein, their conjugative metabolites, as well as their major microbial degradation products in order to provide a method for use in large clinical trials or animal studies. An automated, 96-well solid-phase extraction method was used to extract the isoflavone analytes from plasma and urine. Separation of genistein, daidzein, and 19 of its metabolites, including five glucuronides, seven sulfates, and two sulfoglucuronides, as well as five microbial metabolites, was achieved in less than 25 min using a sub-2 mu m particle column and a gradient elution with acetonitrile/methanol/water as mobile phases. Analysis was performed under negative ionization electrospray MS via the multiple reaction monitoring (MRM). Validation was performed according to the analytical method validation guidelines of Food and Drug Administration (FDA) and International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) consisting of selectivity, accuracy, precision, linearity, limit of detection, recovery, matrix effect, and robustness. All validated parameters essentially matched the FDA and ICH requirements. The application of this method to a pharmacokinetic study in postmenopausal women showed that isoflavones are extensively metabolized in vivo. A robust automated analytical approach was developed, which allows the handling of large sample sizes but nevertheless provides detailed information on the isoflavone metabolite profile leading to a better understanding and interpretation of clinical and animal studies.
引用
收藏
页码:6007 / 6020
页数:14
相关论文
共 48 条
  • [41] Letter to the editor regarding "Development and validation of a sensitive UHPLC-MS/MS method for simultaneous analysis of tramadol, dextromethorphan chlorpheniramine and their major metabolites in human plasma in forensic context: application to pharmacokinetics'
    Zhang, Na
    BIOMEDICAL CHROMATOGRAPHY, 2016, 30 (04) : 663 - 664
  • [42] Fast and single method for quantitation of ricinine or L-abrine in plasma and urine by ultra-high performance liquid chromatography coupled to tandem mass spectrometry (UHPLC-MS/MS)
    Le Roy, Beatrice
    Livet, Sandrine
    Taudon, Nicolas
    TOXICOLOGIE ANALYTIQUE ET CLINIQUE, 2021, 33 (03) : 182 - 192
  • [43] Validated LC-MS/MS method for simultaneous quantification of resveratrol levels in mouse plasma and brain and its application to pharmacokinetic and brain distribution studies
    Ramalingam, Prakash
    Ko, Young Tag
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2016, 119 : 71 - 75
  • [44] A rapid, accurate and robust UHPLC-MS/MS method for quantitative determination of BMS-927711, a CGRP receptor antagonist, in plasma in support of non-clinical toxicokinetic studies
    Zheng, Naiyu
    Zeng, Jianing
    Akinsanya, Billy
    Buzescu, Adela
    Xia, Yuan-Qing
    Ly, Van
    Trouba, Kevin
    Peng, Qianping
    Aubry, Anne-Francoise
    Arnold, Mark E.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 83 : 237 - 248
  • [45] HPLC-ESI-MS/MS validated method for simultaneous quantification of zopiclone and its metabolites, N-desmethyl zopiclone and zopiclone-N-oxide in human plasma
    Mistri, Hiren N.
    Jangid, Arvind G.
    Pudage, Ashutosh
    Shrivastav, Pranav
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 864 (1-2): : 137 - 148
  • [46] A validated LC-MS/MS method for the simultaneous quantification of the novel combination antibiotic, ceftolozane-tazobactam, in plasma (total and unbound), CSF, urine and renal replacement therapy effluent: application to pilot pharmacokinetic studies
    Parker, Suzanne L.
    Pandey, Saurabh
    Sime, Fekade B.
    Stuart, Janine
    Lipman, Jeffrey
    Roberts, Jason A.
    Wallis, Steven C.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (05) : 921 - 933
  • [47] A large-scale, targeted metabolomics method for the analysis and quantification of metabolites in human plasma via liquid chromatography-mass spectrometry
    McMillen, Teresa S.
    Leslie, Andrew
    Chisholm, Kenneth
    Penny, Susanne
    Gallant, Jeffrey
    Cohen, Alejandro
    Drucker, Arik
    Fawcett, James P.
    Pinto, Devanand M.
    ANALYTICA CHIMICA ACTA, 2023, 1279
  • [48] On-line solid-phase extraction coupled with high-performance liquid chromatography and tandem mass spectrometry (SPE-HPLC-MS-MS) for quantification of bromazepam in human plasma -: An automated method for bioequivalence studies
    Saraiva Goncalves, Jose Carlos
    Monteiro, Tania Maria
    de Miranda Neves, Claudia Silvana
    da Silva Gram, Karla Regina
    Volpato, Nadia Maria
    Silva, Vivian A.
    Caminha, Ricardo
    Bencke Goncalves, Maria do Rocio
    dos Santos, Fabio Monteiro
    da Silveira, Gabriel Estolano
    Noel, Francois
    THERAPEUTIC DRUG MONITORING, 2005, 27 (05) : 601 - 607